Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,244 | 1,495 | 1,910 | 1,053 | 1,271 |
| Marketable Securities | 13,930 | 14,534 | 13,687 | 16,202 | 18,653 |
| Receivables | N/A | N/A | N/A | N/A | 173 |
| TOTAL | $15,887 | $17,449 | $16,766 | $18,686 | $21,362 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 193 | 202 | 211 | 220 | 229 |
| TOTAL | $193 | $202 | $211 | $220 | $229 |
| Total Assets | $16,080 | $17,651 | $16,977 | $18,906 | $21,591 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 165 | 276 | 284 | 600 | 525 |
| Accrued Expenses | 1,761 | 1,751 | 1,566 | 1,363 | 1,946 |
| TOTAL | $1,967 | $2,066 | $1,887 | $1,999 | $2,500 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 190 | 196 | 207 | 223 | 233 |
| TOTAL | $163 | $174 | $184 | $194 | $203 |
| Total Liabilities | $2,130 | $2,240 | $2,071 | $2,193 | $2,703 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,377 | 32,917 | 32,211 | 32,197 | 32,197 |
| Common Shares | 330 | 328 | 322 | 322 | 322 |
| Retained earnings | -251,677 | -248,982 | -246,724 | -243,934 | -240,750 |
| Other shareholders' equity | -1,211 | -1,184 | -1,162 | -1,145 | -1,116 |
| TOTAL | $13,950 | $15,411 | $14,906 | $16,713 | $18,888 |
| Total Liabilities And Equity | $16,080 | $17,651 | $16,977 | $18,906 | $21,591 |